-
Pharmaceuticals
- Digital Health
- Radiology
- Speciality Medicine & General Medicine
- Clinical trials
-
Collaboration
- Patient group donations
- Payments to Patients, Public and Media
- Collaborative working
- Completed collaborative working
- Transfers of value to Healthcare Professionals and HealthcareOrganisations
- How Bayer works together with Healthcare Professionals
- What the EFPIA Disclosure code is about
- Data Disclosure
- Donations and Grants
- Consumer Health
- CropScience
Patient Group Donations 2022
Bayer is committed to developing new and innovative therapies for severe and chronic diseases. Patient advocacy groups and other voluntary health organisations help increase disease awareness and effective interventions.
The most recent patient and voluntary health organisations to which Bayer has provided financial support are listed below.
Patient Group Donations (January-December 2022)
Correct at 5 May 2023
Download Patient_Org_Declaration_2022.pdf
(PDF 110.95 KB)
Special Links